Patent · US Active

Nucleic acid molecules for pseudouridylation

US11866702B2 · kind B2 · utility

0Cited by
2References
24Claims
0Family size

Assignees

Inventors

Key dates

Filing dateMar 27, 2019
Grant dateJan 9, 2024
Priority date
Expiry dateJun 18, 2039

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12N2310/335
  • WIPO fieldBiotechnology
  • WIPO sectorChemistry

Abstract

The invention relates to nucleic acid molecules for pseudouridylation of a target uridine in a target RNA in a mammalian cell, wherein the nucleic acid molecule comprises a guide region capable of forming a partially double stranded nucleic acid complex with the target RNA comprising the target uridine, wherein the partially double stranded nucleic acid complex is capable of engaging a mammalian pseudouridylation enzyme, wherein the guide region assists in positioning the target uridine in the partially double stranded nucleic acid complex for it to be converted to a pseudouridine by the mammalian pseudouridylation enzyme.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.